CN107927763A - 一种抗衰老的海洋低温sod保健品 - Google Patents
一种抗衰老的海洋低温sod保健品 Download PDFInfo
- Publication number
- CN107927763A CN107927763A CN201711103092.6A CN201711103092A CN107927763A CN 107927763 A CN107927763 A CN 107927763A CN 201711103092 A CN201711103092 A CN 201711103092A CN 107927763 A CN107927763 A CN 107927763A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- vitamin
- low temperature
- health products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 33
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 89
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 25
- 239000011707 mineral Substances 0.000 claims abstract description 25
- 235000010755 mineral Nutrition 0.000 claims abstract description 25
- 235000015097 nutrients Nutrition 0.000 claims abstract description 21
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 21
- 239000005017 polysaccharide Substances 0.000 claims abstract description 21
- 229940088594 vitamin Drugs 0.000 claims abstract description 21
- 229930003231 vitamin Natural products 0.000 claims abstract description 21
- 235000013343 vitamin Nutrition 0.000 claims abstract description 21
- 239000011782 vitamin Substances 0.000 claims abstract description 21
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 17
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 12
- 235000012054 meals Nutrition 0.000 claims abstract description 12
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 11
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 11
- 150000001413 amino acids Chemical class 0.000 claims abstract description 11
- 235000008434 ginseng Nutrition 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 235000013312 flour Nutrition 0.000 claims abstract description 8
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 5
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 5
- 244000061520 Angelica archangelica Species 0.000 claims abstract 2
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract 2
- 150000004804 polysaccharides Chemical class 0.000 claims description 20
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims description 18
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 18
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 16
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 10
- 235000001014 amino acid Nutrition 0.000 claims description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 9
- 229930064664 L-arginine Natural products 0.000 claims description 9
- 235000014852 L-arginine Nutrition 0.000 claims description 9
- 229960002173 citrulline Drugs 0.000 claims description 9
- 229960003080 taurine Drugs 0.000 claims description 9
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 8
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 8
- 229920001661 Chitosan Polymers 0.000 claims description 8
- 241000251730 Chondrichthyes Species 0.000 claims description 8
- 229920002567 Chondroitin Polymers 0.000 claims description 8
- 241000206754 Palmaria palmata Species 0.000 claims description 8
- 241000195474 Sargassum Species 0.000 claims description 8
- 241000196251 Ulva arasakii Species 0.000 claims description 8
- 229910021529 ammonia Inorganic materials 0.000 claims description 8
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 8
- 239000001921 dulse Substances 0.000 claims description 8
- 235000010413 sodium alginate Nutrition 0.000 claims description 8
- 239000000661 sodium alginate Substances 0.000 claims description 8
- 229940005550 sodium alginate Drugs 0.000 claims description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 7
- 241000206607 Porphyra umbilicalis Species 0.000 claims description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 7
- 235000010443 alginic acid Nutrition 0.000 claims description 7
- 229920000615 alginic acid Polymers 0.000 claims description 7
- 235000019136 lipoic acid Nutrition 0.000 claims description 7
- 239000011777 magnesium Substances 0.000 claims description 7
- 229910052749 magnesium Inorganic materials 0.000 claims description 7
- 229960002663 thioctic acid Drugs 0.000 claims description 7
- 239000011701 zinc Substances 0.000 claims description 7
- 229910052725 zinc Inorganic materials 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052742 iron Inorganic materials 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 239000011669 selenium Substances 0.000 claims description 6
- 229910052711 selenium Inorganic materials 0.000 claims description 6
- 235000019155 vitamin A Nutrition 0.000 claims description 6
- 239000011719 vitamin A Substances 0.000 claims description 6
- 229940045997 vitamin a Drugs 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 5
- 239000004201 L-cysteine Substances 0.000 claims description 5
- 235000013878 L-cysteine Nutrition 0.000 claims description 5
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 5
- 229960001231 choline Drugs 0.000 claims description 5
- 229910052804 chromium Inorganic materials 0.000 claims description 5
- 239000011651 chromium Substances 0.000 claims description 5
- 229910052802 copper Inorganic materials 0.000 claims description 5
- 239000010949 copper Substances 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 235000010445 lecithin Nutrition 0.000 claims description 5
- 239000000787 lecithin Substances 0.000 claims description 5
- 229940067606 lecithin Drugs 0.000 claims description 5
- 229910052750 molybdenum Inorganic materials 0.000 claims description 5
- 239000011733 molybdenum Substances 0.000 claims description 5
- 229960003966 nicotinamide Drugs 0.000 claims description 5
- 235000005152 nicotinamide Nutrition 0.000 claims description 5
- 239000011570 nicotinamide Substances 0.000 claims description 5
- 235000001968 nicotinic acid Nutrition 0.000 claims description 5
- 239000011664 nicotinic acid Substances 0.000 claims description 5
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- 235000016709 nutrition Nutrition 0.000 claims description 5
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims description 5
- 239000011726 vitamin B6 Substances 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- 235000019166 vitamin D Nutrition 0.000 claims description 5
- 239000011710 vitamin D Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 229940011671 vitamin b6 Drugs 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims description 4
- 239000000783 alginic acid Substances 0.000 claims description 4
- 229960001126 alginic acid Drugs 0.000 claims description 4
- 150000004781 alginic acids Chemical class 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims description 4
- 239000011716 vitamin B2 Substances 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- 241000206575 Chondrus crispus Species 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 229930003779 Vitamin B12 Natural products 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010410 calcium alginate Nutrition 0.000 claims description 2
- 239000000648 calcium alginate Substances 0.000 claims description 2
- 229960002681 calcium alginate Drugs 0.000 claims description 2
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 2
- 229960002433 cysteine Drugs 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 229940055726 pantothenic acid Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- 235000010408 potassium alginate Nutrition 0.000 claims description 2
- 239000000737 potassium alginate Substances 0.000 claims description 2
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 2
- 229960003495 thiamine Drugs 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000019163 vitamin B12 Nutrition 0.000 claims description 2
- 239000011715 vitamin B12 Substances 0.000 claims description 2
- 229920002101 Chitin Polymers 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 19
- 102000008186 Collagen Human genes 0.000 abstract description 5
- 108010035532 Collagen Proteins 0.000 abstract description 5
- 229920001436 collagen Polymers 0.000 abstract description 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000004089 microcirculation Effects 0.000 abstract description 2
- 210000004927 skin cell Anatomy 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 230000037303 wrinkles Effects 0.000 abstract description 2
- 150000004676 glycans Chemical class 0.000 abstract 1
- 230000032683 aging Effects 0.000 description 18
- 239000000047 product Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 241000125175 Angelica Species 0.000 description 10
- 241000208340 Araliaceae Species 0.000 description 10
- 239000003963 antioxidant agent Substances 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 235000004879 dioscorea Nutrition 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 150000002484 inorganic compounds Chemical class 0.000 description 4
- 229910010272 inorganic material Inorganic materials 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 150000002894 organic compounds Chemical class 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 230000004224 protection Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 3
- 229930014669 anthocyanidin Natural products 0.000 description 3
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 3
- 235000008758 anthocyanidins Nutrition 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000004681 ovum Anatomy 0.000 description 3
- -1 oxygen radical Chemical class 0.000 description 3
- 230000009758 senescence Effects 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 206010014561 Emphysema Diseases 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010029164 Nephrotic syndrome Diseases 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 201000001981 dermatomyositis Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 229940083565 folic acid 0.8 mg Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 206010025135 lupus erythematosus Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 208000009928 nephrosis Diseases 0.000 description 2
- 231100001027 nephrosis Toxicity 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- 229940084609 vitamin b 12 0.5 mg Drugs 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241001444063 Aronia Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010010075 Coma hepatic Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012374 Depressed mood Diseases 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 241000234272 Dioscoreaceae Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010016275 Fear Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241001282135 Poromitra oscitans Species 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 206010049771 Shock haemorrhagic Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010048232 Yawning Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 208000017580 chronic wasting disease Diseases 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000010501 heavy metal poisoning Diseases 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 201000001059 hepatic coma Diseases 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 230000000701 neuroleptic effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000007105 physical stamina Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 210000003708 urethra Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940072791 vitamin b 12 0.6 mg Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种抗衰老的海洋低温SOD保健品，由以下重量份原料混合制成：海洋低温SOD：10~30份，海洋生物活性多糖：1.5~2.0份，山药粉：1.5~5.0份，西洋参粉：1.5~5.0份，黑果腺肋花楸粉1.5~5.5份，当归粉：1.5~2.0份，海藻粉：1.5~2.0份，营养氨基酸：1.5~2.5份，低聚糖：1.5~2.5份，营养素0.2~0.8份，维生素：0.03~0.10份，矿物质：0.2‑1.0份。本发明保健品可以促进微循环，加快肌肤细胞更新，有助于胶原蛋白的合成，舒缓表皮皮肤，抚平皱纹，有利于提高人体的抗衰老能力。
Description
技术领域
本发明涉及保健品及其制备方法技术领域，具体是一种抗衰老的海洋低温SOD保健品。
背景技术
衰老是由自然因素或非自然因素造成的皮肤衰老现象，是生物随着时间的推移，自发的必然过程，是复杂的自然现象，表现为结构的退行性变和机能的衰退，适应性和抵抗力减退。衰老一直是生命过程中的核心环节，也是影响整个人类社会健康发展的重要问题。抗衰老药物能在一定程度上延缓衰老，促进身体健康，在遗传因素决定的寿限内，保持较好智力和体力。人出生后皮肤组织日益发达，功能逐渐活跃，当到达某种年龄就会开始退化，这种退化往往在人们不知不觉中慢慢进行。皮肤组织的成长期一般结束于25岁左右，有人称此期为“皮肤的弯角”，自此后生长与老化同时进行，皮肤弹力纤维渐渐变粗，40-50岁初老期，皮肤的老化慢慢明显，但老化程度因人而异。皮肤老化为多因素所致，概括起来有9个方面：1.年龄因素；皮肤老化一般从30岁左右开始，此为唯一的不可避免的因素，其余诸因素均可改变。2.健康因素；患肾病、肝病、妇科病等慢性消耗性疾病时，皮肤易老化。3.精神因素；用脑过度、思虑过多、心情烦闷皮肤易老化。4.营养因素；由于咀嚼不良和胃肠功能衰弱、营养失调，或饮食中缺乏蛋白质和各种维生素时，皮肤易老化。5.生活习惯；熬夜、过度疲劳及抽烟均可加速皮肤衰老。6.环境因素；长期阳光暴晒，风吹雨淋，或海水侵蚀者，皮肤易衰老。7.内分泌紊乱；妇女绝经后，雌性激素分泌减少，从而影响皮肤的充实度和弹性。8.皮肤保养不当。9.用药不当；不恰当使用药疗药物或化妆品易使皮肤老化。
每个人都害怕自己衰老，总是想要时光多停留一会儿。因此，众多抗衰老产品也运营而生。如今，市面上的抗衰老护肤产品有些含有维生素A、胜肽，这些产品只能在夜间使用；或是通过在面霜或精华里面添加胶原蛋白涂抹的方式给皮肤增加胶原蛋白。胶原蛋白，首先它是一种蛋白，蛋白的分子很大，大到不要说肌肤根本无法吸收，就连我们赖以其吸收养分才能生存的胃肠也是要先把它水解为氨基酸才能吸收。因此，市场上缺少一种具有抗癌抗菌、抗衰老、排毒养颜美容功效的保健品。
发明内容
本发明的目的是提供一种抗衰老的海洋低温SOD保健品。
为实现上述发明目的，本发明采用以下技术方案：
一种抗衰老的海洋低温SOD保健品，其特征在于，由以下重量份原料混合制成：
海洋低温SOD：10~30份，
海洋生物活性多糖：1.5~2.0份，
山药粉：1.5~5.0份，
西洋参粉：1.5~5.0份，
黑果腺肋花楸粉1.5~5.5份，
当归粉：1.5~2.0份，
海藻粉：1.5~2.0份，
营养氨基酸：1.5~2.5份，
低聚糖：1.5~2.5份，
营养素0.2~0.8份，
维生素：0.03~0.10份，
矿物质：0.2-1.0份。
本发明保健品可以制成粉状、片状、颗粒状或丸状，以温开水溶解后食用。
本发明所用主要原料为：
1.海洋低温SOD：
本发明所述的海洋低温SOD是以海洋细菌为原料进行发酵生产的安全性及稳定性较高的SOD。
（1）抑制心脑血管疾病：机体的衰老与体内氧自由基的产生与积累密切相关， SOD可清除人体内过多的有害的氧自由，是对健康的有益的功效成分。具有调节血脂的保健作用，可预防动脉粥样硬化，预防高血脂引起的心脑血管疾病。降低脂质过氧化物的含量。（2）抗衰老：年龄的增长和某些体外因素会造成机体和皮肤组织自由基产生超过机体正常清除自由基的的能力，从而使皮肤组织造成伤害，导致衰老。由于SOD能够清除自由基，因而可以延缓衰老。人之所以会衰老，老化迹象一点一滴出观，如色素沉淀、体力衰退、是因为体内产生氧化作用，所谓“氧化作用”就类似于生锈，抗氧化剂的补充有助于降低氧化的速度，减慢衰老的脚步。（3）防治自身免疫性疾病：SOD对各类自身免疫性疾病都有一定的疗效。如红斑狼疮、硬皮病、皮肌炎等。对于类风湿关节炎患者应在急性期病变未形成前使用，疗效较好。（4）肺气肿：肺气肿患者亦可使用 SOD ，但应在病变初期肺弹性纤维尚未受到损害时使用，疗效较好。（5）辐射病及辐射防护：该品可用来治疗因放疗引起的膀胱炎、皮肌炎、红斑狼疮及白细胞减少等疾病，对有可能受到电离辐射的人员，也可注射 SOD 作为预防措施。（6）老年性白内障：对这类疾病应在进入老年期前即开始经常服用抗氧化剂，或者说经常注射SOD。一旦形成白内障，则应该摘除，因为此时使用SOD无效。（7）抗氧化：医学报告指出， 抗氧化能力的衰退期已提前至40岁左右，光靠蔬果已经不足以消除人体内外共同形成的氧化压力。（8）预防慢性病：自由基是科学家已发现导致各种慢性病与老化的罪魁祸首，故说它是“万病之源”，是人体健康的大敌，自由基对身体的伤害是日积月累的，尤其是糖尿病与心血管方面的疾病。（9）抗疲劳：过多的自由基在体内残存，就犹如毒素蓄积在体内一样，会让人：容易疲劳、厌倦、注意力不集中、常常昏昏沉沉、打哈欠。SOD对上班族熬夜加班、学生应付考试所产生的疲劳，在提振精神及集中注意力方面成效显著，有助于工作绩效的提升，及考试成绩的进步。（10）消除副作用：接受化疗的癌症病患体内的抗氧化能力会大大地降低，万一低到某个程度，自由基就会损害细胞、黏膜、五脏六腑、脑、中枢神经等．所以癌症患者应及时补充抗氧化剂来维持好体力。日本厚生省与美国癌症中心（NCI）均建议使用抗氧化剂来预防癌症或治疗因氧自由基破坏细胞所引起的病变，降低抗癌药物所引起的如呕吐、食欲不振、掉发等副作用。（11）避免二次伤害：手术会引起大量自由基，故建议手术前后口服抗氧化剂来迅速恢复体力，加速伤口复原。（12）有效降低血脂、胆固醇、血压；（13）抗辐射；（14）增强肝肾功能；（15）对糖尿病有明显的恢复作用。
2.海洋生物活性多糖：
本发明所述的海洋生物活性多糖为海洋动物多糖、海藻多糖和海洋壳类多糖中的一种、几种或全部，其中所述的海洋动物多糖为糖胺聚糖和鲨鱼软骨素中的一种或两种，所述的海藻多糖为琼脂、海藻酸钠、卡拉胶、岩藻多糖、海藻酸钾、海藻酸钙、海藻酸锌、海藻酸铁和海藻酸镁中的一种、几种或全部，所述的海洋壳类多糖为珍珠粉、珍珠层粉、几丁聚糖、几丁寡糖、氨糖中的一种、几种或全部。
3.山药粉
本发明所述的山药粉为薯蓣科植物山药干燥根茎磨制而成。具有健脾益胃、助消化；滋肾益精；益肺止咳；降低血糖；延年益寿；抗肝昏迷的功效。
4.西洋参粉
本发明所述的西洋参粉为五加科，人参属的西洋参磨制而成。可以改善心肌功能，抗缺血，抗心律失常，抗休克，抗动脉硬化；增强体质，抗缺氧，抗疲劳，耐高温，耐寒耐饥渴；促进造血；镇静；降血糖；增强免疫力。
5.黑果腺肋花楸粉
本发明所述的黑果腺肋花楸粉为蔷薇科腺肋花楸属植物黑果腺肋花楸树的果实晒干磨制而成。
黑果腺肋花楸中花青素、黄酮（鲜果含量高达0.25%-0.35%）、多酚是已知植物中含量最高的，还含有多种维生素和矿质元素等物质。多酚是改善毛细血管和血管的结构与机能的非常重要的物质，还有助于刺激和改善循环系统。花青素和黄酮能够维持人的心脏和机体的健康。据报道，花青素和黄酮（及其糖苷）有助于保持尿道健康。黑果腺肋花楸果实富含Vc和抗氧化剂（Beta Carotene(胡萝卜素)），抗氧化剂具有抗衰老功能。果实提取物对治疗辐射病和重金属中毒症有很好的疗效。
6.当归粉
本发明所述的当归粉为伞形科当归属的植物当归磨制而成。具有抗缺氧作用；调节机体免疫功能、具有抗癌作用；护肤美容作用；补血活血作用；抑菌、抗动脉硬化作用。
7.海藻粉
食源性海洋藻类富含海藻胶、甘露醇、维生素和多种矿物质元素如钾、铁、钙、磷、碘、硒、钴等微量元素，还含粗蛋白10％-40％，粗脂肪0.30％-50％，碳水化合物30％-60％。科学研究表明，海藻粉可以调节人体的新陈代谢机能，增强免疫力、保健、补脑增智、抗衰老，可以预防甲状腺肿大、肾病，增强皮肤光泽和弹性、软化血管、降低胆固醇，是一种美容佳品；还可以降脂、降压，防止肥胖病、高血压、心血管病等。
本发明所述的海藻粉为褐藻粉、马尾藻粉、掌状红皮藻粉、石莼粉、海带粉、紫菜粉、巨藻粉中的一种、几种或全部。
本发明所述的海藻粉，是指将海藻洗净、除腥、滤杂、烘干、粉碎而制备的粉状物质。
8.营养氨基酸：
氨基酸是构成生物体蛋白质并同生命活动有关的最基本的物质，是在生物体内构成蛋白 质分子的基本单位，与生物的生命活动有着密切的关系。它在抗体内具有特殊的生理功能， 是生物体内不可缺少的营养成分之一，经医学研究证实，L-精氨酸、牛磺酸、L-瓜氨酸、L- 半胱氨酸、L-丙氨酸具有护肝养肝的功能。
本发明所述的营养氨基酸为L-精氨酸、牛磺酸、L-瓜氨酸、L-半胱氨酸和L-丙氨酸中的 一种、几种或全部。
9.营养素：
营养素是人体细胞产生能量必需的物质。它广泛存在于生物体中，在人体内，主要集中消耗能量较多的部位，可用作肝损伤的营养支援。
本发明所述的营养素为卵磷脂、辅酵素Q10和a-硫辛酸中的一种或全部。
10.维生素和矿物质：
维生素和矿物质是人体必需的营养素。
本发明所述的维生素为维生素A、维生素D、维生素E、维生素C、维生素B1、维生素B2、维生素B6、维生素B12、烟酸、叶酸、泛酸、胆碱和烟酰胺中的一种、几种或全部。
本发明所述的矿物质为钙、钾、镁、铁、锌、硒、锰、铜、铬和钼中的一种、几种或全部。
本发明所述的矿物质的添加形式为该矿物质的有机或无机化合物。
本发明中维生素矿物质的添加量参照2000年中国营养学会颁布的《中国居民膳食营养素参考摄入量》、《食品营养强化剂使用卫生标准》(GB14880-1994)和2005年7月1日国家食品药品监督管理局正式开始实施的《营养素补充剂申报与审评规定(试行)》中规定的《维生素、矿物质种类和用量》执行。
上述各种配料混合均匀，可保持其粉状，或经过造粒，制成粉状、片状或颗粒状。
与现有技术相比，本发明的有益效果：本发明提供的海洋低温SOD保健品易溶解，对人体有最大的生物吸收度和最大的生物利用度，参考了海洋生物学和海洋生命科学的研究成果，将现代营养学的研究成果与传统养生保健理论相结合，配比优良，为机体提供活性因子和营养成分，补充人体必需的多种维生素和矿物质，所选草本植物毒副作用低，可以促进微循环，加快肌肤细胞更新，有助于胶原蛋白的合成，舒缓表皮皮肤，抚平皱纹，有利于提高人体的抗衰老能力。
具体实施方式
以下实施例仅用于阐述本发明，而本发明的保护范围并非仅仅局限于以下实施例。所述技术领域的普通技术人员依据以上本发明公开的内容和各参数所取范围，均可实现本发明的目的。
实施例1
本实施例选择海洋低温SOD、海藻酸钠、岩藻多糖、几丁聚糖、鲨鱼软骨素、糖氨聚糖、山药粉、西洋参粉、黑果腺肋花楸粉、当归粉、褐藻粉、马尾藻粉、掌状红皮藻粉、石莼粉、海带粉、紫菜粉、巨藻粉、牛磺酸、L-精氨酸、L-瓜氨酸、L-半胱氨酸、L-丙氨酸、 麦芽低聚糖、卵磷脂、辅酵素Q10、α-硫辛酸及各种维生素、矿物质、按下列重量配比进行制备：
(1)海洋低温SOD：10g；
(2)海洋生物活性多糖：海藻酸钠0.3g、岩藻多糖0.3g、几丁聚糖0.4g、鲨鱼软骨素0.5g、糖胺聚糖0.4g；
(3)山药粉1.5g；
(4)西洋参粉2.0g；
(5)黑果腺肋花楸粉2.0g；
(6)当归粉1.5g；
(7)海藻粉：褐藻粉0.6g、马尾藻粉0.3g、掌状红皮藻粉0.3g、石莼粉0.2g、海带粉0.2g、紫菜粉 0.2g、巨藻粉0.2g；
(8)营养氨基酸：牛磺酸0.4g、L-精氨酸0.4g、L-瓜氨酸0.5g、L-半胱氨酸0.6g、L-丙氨酸0.5g；
(9)营养素：卵磷脂0.6g、辅酵素Q10 0.07g、α-硫辛酸0.07g；
(10)维生素：维生素A 0.6mg、维生素E 5.4mg、维生素C 38mg、维生素D 0.3mg、维生素B1 0.6mg、维生素B2 1.5mg、维生素B61.5mg、维生素B120.5mg、烟酸0.8mg、叶酸0.8mg、 泛酸3mg、胆碱45mg、烟酰胺0.6mg；
(11)矿物质(矿物质的添加形式为该矿物质的有机或无机化合物)：钙310mg、钾120mg、镁60mg、铁6mg、锌6mg、硒0.05mg、锰2mg、铬0.1mg、铜0.5mg、钼0.1mg；以上所用原料均可通过市售购买到。
将上述原料混合，搅拌均匀，经过干燥，制成粉状。用约150mL温开水溶解后，直接饮用。
本发明保健品对(·OH)的清除率为92. 3%，对超氧阴离子(O2-·)的清除率达96.5%，对 (DPPH·)的清除率达92.9%。
实施例2
本实施例选择海洋低温SOD、海藻酸钠、岩藻多糖、几丁聚糖、鲨鱼软骨素、糖氨聚糖、山药粉、西洋参粉、黑果腺肋花楸粉、当归粉、褐藻粉、马尾藻粉、掌状红皮藻粉、石莼粉、海带粉、紫菜粉、巨藻粉、牛磺酸、L-精氨酸、L-瓜氨酸、L-半胱氨酸、L-丙氨酸、 麦芽低聚糖、卵磷脂、辅酵素Q10、α-硫辛酸及各种维生素、矿物质、按下列重量配比进行制备：
(1)海洋低温SOD：15g；
(2)海洋生物活性多糖：海藻酸钠0.4g、岩藻多糖0.3g、几丁聚糖0.4g、鲨鱼软骨素0.3g、糖胺聚糖0.2g；
(3)山药粉3.0g；
(4)西洋参粉3.0g；
(5)黑果腺肋花楸粉3.0g；
(6)当归粉1.6g；
(7)海藻粉：褐藻粉0.4g、马尾藻粉0.4g、掌状红皮藻粉0.2g、石莼粉0.2g、海带粉0.2g、紫菜粉 0.2g、巨藻粉0.2g；
(8)营养氨基酸：牛磺酸0.3g、L-精氨酸0.3g、L-瓜氨酸0.3g、L-半胱氨酸0.3g、L-丙氨酸0.5g；
(9)营养素：卵磷脂0.5g、辅酵素Q10 0.08g、α-硫辛酸0.06g；
(10)维生素：维生素A 0.6mg、维生素E 5.4mg、维生素C 40mg、维生素D 0.3mg、维生素B1 0.6mg、维生素B2 1.5mg、维生素B61.5mg、维生素B120.6mg、烟酸0.7mg、叶酸0.7mg、 泛酸1mg、胆碱40mg、烟酰胺0.6mg；
(11)矿物质(矿物质的添加形式为该矿物质的有机或无机化合物)：钙300mg、钾130mg、镁50mg、铁8mg、锌8mg、硒0.06mg、锰4mg、铬0.1mg、铜0.5mg、钼0.1mg；以上所用原料均可通过市售购买到。
将上述原料混合，搅拌均匀，经过干燥，制成粉状。用约150mL温开水溶解后，直接饮用。
本发明保健品对(·OH)的清除率为94. 7%，对超氧阴离子(O2-·)的清除率达95.8%，对 (DPPH·)的清除率达93.1%。
实施例3
本实施例选择海洋低温SOD、海藻酸钠、岩藻多糖、几丁聚糖、鲨鱼软骨素、糖氨聚糖、山药粉、西洋参粉、黑果腺肋花楸粉、当归粉、褐藻粉、马尾藻粉、掌状红皮藻粉、石莼粉、海带粉、紫菜粉、巨藻粉、牛磺酸、L-精氨酸、L-瓜氨酸、L-半胱氨酸、L-丙氨酸、 麦芽低聚糖、卵磷脂、辅酵素Q10、α-硫辛酸及各种维生素、矿物质、按下列重量配比进行制备：
(1)海洋低温SOD：30g；
(2)海洋生物活性多糖：海藻酸钠0.4g、岩藻多糖0.4g、几丁聚糖0.4g、鲨鱼软骨素0.4g、糖胺聚糖0.4g；
(3)山药粉5.0g；
(4)西洋参粉5.0g；
(5)黑果腺肋花楸粉3.0g；
(6)当归粉2.0g；
(7)海藻粉：褐藻粉0.6g、马尾藻粉0.3g、掌状红皮藻粉0.3g、石莼粉0.2g、海带粉0.2g、紫菜粉 0.2g、巨藻粉0.2g；
(8)营养氨基酸：牛磺酸0.4g、L-精氨酸0.4g、L-瓜氨酸0.5g、L-半胱氨酸0.6g、L-丙氨酸0.5g；
(9)营养素：卵磷脂0.6g、辅酵素Q10 0.07g、α-硫辛酸0.07g；
(10)维生素：维生素A 0.6mg、维生素E 5.4mg、维生素C 38mg、维生素D 0.3mg、维生素B1 0.6mg、维生素B2 1.5mg、维生素B61.5mg、维生素B120.5mg、烟酸0.8mg、叶酸0.8mg、 泛酸3mg、胆碱45mg、烟酰胺0.6mg；
(11)矿物质(矿物质的添加形式为该矿物质的有机或无机化合物)：钙310mg、钾120mg、镁60mg、铁6mg、锌6mg、硒0.05mg、锰2mg、铬0.1mg、铜0.5mg、钼0.1mg；以上所用原料均可通过市售购买到。
将上述原料混合，搅拌均匀，经过干燥，制成粉状。用约150mL温开水溶解后，直接饮用。
本发明保健品对(·OH)的清除率为94. 7%，对(O2-·)的清除率达95. 8%，对(DPPH·)的清除率达93.1%。
本发明的保护范围并非仅仅局限于以上实施例。本技术领域的普通技术人员依据以上公开的内容和各参数所取范围，均可实现本发明的目的，均在本发明保护范围内。
Claims (8)
1.一种抗衰老的海洋低温SOD保健品，其特征在于，由以下重量份原料混合制成：
海洋低温SOD：10~30份，
海洋生物活性多糖：1.5~2.0份，
山药粉：1.5~5.0份，
西洋参粉：1.5~5.0份，
黑果腺肋花楸粉1.5~5.5份，
当归粉：1.5~2.0份，
海藻粉：1.5~2.0份，
营养氨基酸：1.5~2.5份，
低聚糖：1.5~2.5份，
营养素0.2~0.8份，
维生素：0.03~0.10份，
矿物质：0.2-1.0份。
2.根据权利要求1所述的抗衰老的海洋低温SOD保健品，其特征在于，所述的海洋生物活性多糖为海洋动物多糖、海藻多糖和海洋壳类多糖中的一种、几种或全部，其中所述的海洋动物多糖为糖胺聚糖和鲨鱼软骨素中的一种或两种，所述的海藻多糖为琼脂、海藻酸钠、卡拉胶、岩藻多糖、海藻酸钾、海藻酸钙、海藻酸锌、海藻酸铁和海藻酸镁中的一种、几种或全部，所述的海洋壳类多糖为珍珠粉、珍珠层粉、几丁聚糖、几丁寡糖、氨糖中的一种、几种或全部。
3.根据权利要求1所述的抗衰老的海洋低温SOD保健品，其特征在于，所述的海藻粉为褐藻粉、马尾藻粉、掌状红皮藻粉、石莼粉、海带粉、紫菜粉、巨藻粉中的一种、几种或全部。
4.根据权利要求1所述的抗衰老的海洋低温SOD保健品，其特征在于，所述的营养氨基酸为L-精氨酸、牛磺酸、L-瓜氨酸、L-半胱氨酸和L-丙氨酸中的一种、几种或全部。
5.根据权利要求1所述的抗衰老的海洋低温SOD保健品，其特征在于，所述的营养素为卵磷脂、辅酵素Q10和α-硫辛酸中的一种或全部。
6.根据权利要求1所述的抗衰老的海洋低温SOD保健品，其特征在于，所述的维生素为维生素A、维生素D、维生素E、维生素C、维生素B1、维生素B2、维生素B6、维生素B12、烟酸、叶酸、泛酸、胆碱和烟酰胺中的一种、几种或全部。
7.根据权利要求1所述的抗衰老的海洋低温SOD保健品，其特征在于，所述的矿物质为钙、钾、镁、铁、锌、硒、锰、铜、铬和钼中的一种、几种或全部。
8.根据权利要求1所述的抗衰老的海洋低温SOD保健品，其特征在于，所述的保健品可制成粉状、片状、颗粒状、丸状或其他食品上可接受的剂型。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711103092.6A CN107927763A (zh) | 2017-11-10 | 2017-11-10 | 一种抗衰老的海洋低温sod保健品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711103092.6A CN107927763A (zh) | 2017-11-10 | 2017-11-10 | 一种抗衰老的海洋低温sod保健品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107927763A true CN107927763A (zh) | 2018-04-20 |
Family
ID=61933755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711103092.6A Pending CN107927763A (zh) | 2017-11-10 | 2017-11-10 | 一种抗衰老的海洋低温sod保健品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107927763A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113491332A (zh) * | 2021-06-08 | 2021-10-12 | 杨宝亮 | 一种含有sod的全氨基酸营养素食品 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102077938A (zh) * | 2010-09-20 | 2011-06-01 | 王强 | 一种肝损伤患者专用的海洋特膳食品 |
| CN102653737A (zh) * | 2012-04-13 | 2012-09-05 | 大连大学 | 海洋微生物发酵生产低温超氧化物歧化酶的方法 |
| CN104605287A (zh) * | 2015-02-15 | 2015-05-13 | 陕西思尔生物科技有限公司 | 一种含支链氨基酸的黑果腺肋花楸食品 |
| CN105519743A (zh) * | 2016-02-04 | 2016-04-27 | 浙江醒缘生物科技有限公司 | 一种含有益气补血养颜、抗疲劳抗衰老中草药的保健茶 |
-
2017
- 2017-11-10 CN CN201711103092.6A patent/CN107927763A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102077938A (zh) * | 2010-09-20 | 2011-06-01 | 王强 | 一种肝损伤患者专用的海洋特膳食品 |
| CN102653737A (zh) * | 2012-04-13 | 2012-09-05 | 大连大学 | 海洋微生物发酵生产低温超氧化物歧化酶的方法 |
| CN104605287A (zh) * | 2015-02-15 | 2015-05-13 | 陕西思尔生物科技有限公司 | 一种含支链氨基酸的黑果腺肋花楸食品 |
| CN105519743A (zh) * | 2016-02-04 | 2016-04-27 | 浙江醒缘生物科技有限公司 | 一种含有益气补血养颜、抗疲劳抗衰老中草药的保健茶 |
Non-Patent Citations (1)
| Title |
|---|
| 许娟: "《家庭用药一点通》", 30 September 2006, 中国中医药出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113491332A (zh) * | 2021-06-08 | 2021-10-12 | 杨宝亮 | 一种含有sod的全氨基酸营养素食品 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102077936B (zh) | 一种糖尿病患者专用的海洋特膳食品 | |
| CN106072573A (zh) | 一种适用于老年肌肉衰减症食用的特膳食品 | |
| CN102077939B (zh) | 一种肥胖人士专用的海洋特膳食品 | |
| CN102077940B (zh) | 一种冠心病患者专用的海洋特膳食品 | |
| CN102077945B (zh) | 一种人流、产后专用的海洋特膳食品 | |
| CN102077937B (zh) | 一种中青年女士专用的海洋特膳食品 | |
| CN102077938B (zh) | 一种肝损伤患者专用的海洋特膳食品 | |
| DE202007011252U1 (de) | Aminozucker-enthaltendes Produkt | |
| CN102077934A (zh) | 一种高血压患者专用的海洋特膳食品 | |
| CN103976203B (zh) | 一种美容养颜的果冻及其制备方法 | |
| CN102077942B (zh) | 一种骨病患者专用的海洋特膳食品 | |
| CN107455698A (zh) | 一种用于促进智力发育的海洋多肽特膳食品 | |
| CN102077944B (zh) | 一种前列腺患者专用的海洋特膳食品 | |
| KR101123208B1 (ko) | 체중감량 및 체지방분해를 위한 체중조절용 식품의 제조방법 및 상기 방법에 의해 제조된 기능성 식품 | |
| CN107616507A (zh) | 一种供慢性关节炎患者食用的海洋多肽特膳食品 | |
| CN107495387A (zh) | 一种作为运动补剂的海洋多肽特膳食品 | |
| CN104431170A (zh) | 改善代谢综合征六高一脂的海洋生物活性多糖或寡糖颗粒茶饮 | |
| CN103976202A (zh) | 一种可食用胶原蛋白果冻及其制备方法 | |
| CN102077943B (zh) | 一种记忆力衰退者专用的海洋特膳食品 | |
| CN107927763A (zh) | 一种抗衰老的海洋低温sod保健品 | |
| CN107549692A (zh) | 一种用于化疗患者术后恢复的海洋多肽特膳食品 | |
| CN102077935B (zh) | 一种视力衰退患者专用的海洋特膳食品 | |
| CN108013459A (zh) | 一种具有减肥美容功能的保健食品及其制备方法 | |
| CN102077941B (zh) | 一种更年期女士专用的海洋特膳食品 | |
| KR20210060776A (ko) | 비만 예방 및 부종 개선용 음료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180420 |
|
| WD01 | Invention patent application deemed withdrawn after publication |